1
|
Gregorc V, Bulotta A, Viganò M, Citterio G, Petrella G, Brioschi E, Ducceschi M, Gianni L, Colombi S, Rossoni G, Salini G, Savia V, Lambiase A, Bordignon C. Patient-reported outcomes (PROs) and impact of lactate dehydrogenase (LDH) levels on outcomes in a phase 3 trial (NGR015) with best investigator choice (BIC) plus or minus NGR-hTNF in previously treated patients with malignant pleural mesothelioma (MPM). Ann Oncol 2016. [DOI: 10.1093/annonc/mdw391.01] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
2
|
Gambi F, De Berardis D, Sepede G, Campanella D, Galliani N, Carano A, La Rovere L, Salini G, Penna L, Cicconetti A, Spinella S, Quartesan R, Salerno RM, Ferro FM. Effect of Mirtazapine on Thyroid Hormones in Adult Patients with Major Depression. Int J Immunopathol Pharmacol 2016; 18:737-44. [PMID: 16388723 DOI: 10.1177/039463200501800417] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
Hypothalamic pituitary thyroid (HPT) axis abnormalities and alterations in major depression are reported in literature. The aim of our study was to evaluate the effect of mirtazapine on thyroid hormones after 6 months of therapy in a sample of adult outpatients with Major Depression (MD). 17 adult outpatients (7 men, 10 women) with MD according to DSM-IV criteria, were included in the study. All participants had to have met criteria for a major depressive episode with a score of at least 15 on the Hamilton Depression Rating Scale (HAM-D). Fasting venous blood samples were obtained for determination of serum Thyroid Stimulating Hrmone (TSH), Free T3 (FT3) and Free T4 (FT4) concentrations both at baseline and after 6 months of therapy. HAM-D scores decreased significantly from the first day of treatment to the end of the treatment period (p<0.001) and twelve patients (70.6%) were classified as responders. A significant increase in FT3 concentrations was found between baseline and the end of treatment period (P=0.015) whereas FT4 concentrations decreased (P=0.046). No significant changes were found in TSH levels. Higher FT4 concentrations at baseline predicted higher HAM-D scorers both at baseline and at the end of the treatment period. Furthermore, higher FT3 concentrations at endpoint were found to be predictors of lower HAM-D scores. Long-term treatment with mirtazapine increases FT3 levels and decreases FT4 maybe involving the deiodination process of T4 into T3.
Collapse
Affiliation(s)
- F Gambi
- Department of Oncology and Neurosciences, Institute of Psychiatry, University G. d' Annunzio, Chieti, Italy.
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
3
|
Gambi F, De Berardis D, Campanella D, Carano A, Sepede G, Salini G, Scorrano B, Spinella S, Conti C, La Rovere R, Valchera A, Mancini E, Ceddia D, Marchionni L, Calcagni E, Cotellessa C, Salerno R, Ferro F. A Retrospective Evaluation of the Inflammatory Marker C-Reactive Protein (CRP), Cholesterol and High-Density Lipoproteins in Patients with Major Depression: Preliminary Findings. EUR J INFLAMM 2016. [DOI: 10.1177/1721727x0500300304] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022] Open
Abstract
The aim of this study was to retrospectively evaluate the role of C-reactive protein, total cholesterol and high-density lipoprotein cholesterol in patients suffering from Major Depression (MD). Data of C-reactive protein, total cholesterol (TC) and high-density lipoprotein cholesterol of 37 adult outpatients (17 men, 20 women) with a DSM-IV diagnosis of MD were analyzed. Depression was measured with the 17-item Hamilton Depression Rating Scale (HAM-D) and with the Beck Depression Inventory (BDI). Suicide risk was evaluated with the Scale of Suicide Ideation (SSI). Patients with a lifetime history of attempted suicide were categorized as having higher suicide risk. Higher suicide risk patients showed higher C-reactive protein levels and lower high-density lipoprotein cholesterol levels than lower suicide risk patients whereas total cholesterol levels were not statistically different. C-reactive protein positively correlated with BDI, HAM-D, SSI scores and with number of previous depressive episodes. High-density lipoprotein cholesterol correlated inversely with BDI, HAM-D and SSI scores, whereas, no significant correlations were found between Total Cholesterol and other variables including C-reactive protein. In linear regression models, C-reactive protein was predictor of more severe depression and increased suicide risk. Lower high-density lipoprotein cholesterol levels were significantly predictive of increased suicide risk.
Collapse
Affiliation(s)
- F. Gambi
- Department of Oncology and Neurosciences, Institute of Psychiatry, University “G. D'Annunzio” of Chieti
| | - D. De Berardis
- Department of Oncology and Neurosciences, Institute of Psychiatry, University “G. D'Annunzio” of Chieti
- ASUR Marche 8
- Marinferm, Italian Navy, Ancona
| | - D. Campanella
- Department of Oncology and Neurosciences, Institute of Psychiatry, University “G. D'Annunzio” of Chieti
| | - A. Carano
- Department of Oncology and Neurosciences, Institute of Psychiatry, University “G. D'Annunzio” of Chieti
| | - G. Sepede
- Department of Oncology and Neurosciences, Institute of Psychiatry, University “G. D'Annunzio” of Chieti
| | - G. Salini
- Department of Oncology and Neurosciences, Institute of Psychiatry, University “G. D'Annunzio” of Chieti
| | - B. Scorrano
- Department of Oncology and Neurosciences, Institute of Psychiatry, University “G. D'Annunzio” of Chieti
| | - S. Spinella
- Department of Oncology and Neurosciences, Institute of Psychiatry, University “G. D'Annunzio” of Chieti
| | - C.M. Conti
- Department of Oncology and Neurosciences, Institute of Psychiatry, University “G. D'Annunzio” of Chieti
| | - R. La Rovere
- Department of Oncology and Neurosciences, Institute of Psychiatry, University “G. D'Annunzio” of Chieti
| | | | - E. Mancini
- Marinferm, Italian Navy, Ancona
- Chinical Psychology, University of Chieti
| | | | | | | | - C. Cotellessa
- Department of Oncology and Neurosciences, Institute of Psychiatry, University “G. D'Annunzio” of Chieti
| | - R.M. Salerno
- Department of Oncology and Neurosciences, Institute of Psychiatry, University “G. D'Annunzio” of Chieti
| | - F.M. Ferro
- Department of Oncology and Neurosciences, Institute of Psychiatry, University “G. D'Annunzio” of Chieti
| |
Collapse
|